Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Triple-Negative Breast Carcinoma
Interventions: DRUG: PD1+ TILs (NUMARZU-001) product infusion
Sponsor: Fundacio Clinic Barcelona
Collaborators: SOLTI Breast Cancer Research Group